Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.